When engaging in joint activities, humans tend to sacrifice some of their own sensorimotor comfort and efficiency to facilitate a partner's performance. In the two experiments reported here, we investigated whether ownership-a socioculturally based nonphysical feature ascribed to objects-influenced facilitatory motor behavior in joint action. Participants passed mugs that differed in ownership status across a table to a partner. We found that participants oriented handles less toward their partners when passing their own mugs than when passing mugs owned by their partners (Experiment 1) and mugs owned by the experimenter (Experiment 2). These findings indicate that individuals plan and execute actions that assist their partners but do so to a smaller degree if it is the individuals' own property that the partners intend to manipulate. We discuss these findings in terms of underlying variables associated with ownership and conclude that a self-other distinction can be found in the human sensorimotor system.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0956797616661544DOI Listing

Publication Analysis

Top Keywords

ownership status
8
passing mugs
8
mugs owned
8
status influences
4
influences degree
4
degree joint
4
joint facilitatory
4
facilitatory behavior
4
behavior engaging
4
engaging joint
4

Similar Publications

Background: Passively-obtained smartphone digital phenotypes may yield objective estimates of everyday cognition in older adults compared to traditional cognitive/self-report measures typically confounded by sociodemographics. However, it is currently unknown what covariates are relevant when interpreting smartphone sensor data. We aimed to clarify which intrinsic and extrinsic factors are associated with digital phenotyping versus traditional cognitive measures in a cohort of older adults.

View Article and Find Full Text PDF

Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.

Am J Psychiatry

January 2025

Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore (Aaronson, Miller, LaPratt, Swartz, Shoultz, Lauterbach); Department of Psychiatry, University of Maryland, Baltimore (Aaronson, van der Vaart, Lauterbach); VA Palo Alto Health Care System and Department of Psychiatry and Behavioral Sciences Stanford University School of Medicine, Palo Alto, CA (Suppes); Departments of Psychiatry and Radiology, Columbia University, New York (Sackeim).

Article Synopsis
  • The study focused on evaluating the safety and effectiveness of psilocybin for patients with severe treatment-resistant depression (TRD), who had not benefited from at least five previous treatments.
  • Conducted over 12 weeks at Sheppard Pratt Hospital, patients received a single 25 mg dose of synthetic psilocybin and underwent therapy sessions before and after dosing, assessing their depression levels mainly with the Montgomery-Åsberg Depression Rating Scale (MADRS).
  • Results showed significant reductions in depressive symptoms at both 3 weeks and 12 weeks post-treatment, indicating psilocybin’s potential as a viable option for individuals with severe TRD, although those with comorbid PTSD experienced less improvement.
View Article and Find Full Text PDF

Background: Since 2012, the northeast region of Tunisia has witnessed an increase in dog rabies cases, indicating a concerning emergence of the disease. Previous studies have indicated the widespread nature of rabies in northern Tunisia. However, there remains a lack of comprehensive understanding regarding the associated risk factors.

View Article and Find Full Text PDF

Background The United States continues to rank as one of the most expensive healthcare systems in the world, and cataract surgery, the most commonly performed surgery, is one of the primary drivers of healthcare expenditure. Increasing efforts have been made to try to minimize U.S.

View Article and Find Full Text PDF

Purpose: Nivolumab plus ipilimumab (NIVO + IPI) is a first-in-class combination immunotherapy for the treatment of intermediate- or poor (I/P)-risk advanced or metastatic renal cell carcinoma (mRCC). Currently, there are limited real-world data regarding clinical effectiveness beyond 12-24 months from treatment initiation. In this real-world study, treatment patterns and clinical outcomes were evaluated for NIVO + IPI in a community oncology setting.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!